3-Dimensional printing in vascular disease: From manufacturer to clinical use.


Journal

Seminars in vascular surgery
ISSN: 1558-4518
Titre abrégé: Semin Vasc Surg
Pays: United States
ID NLM: 8809602

Informations de publication

Date de publication:
Sep 2024
Historique:
received: 14 05 2024
revised: 23 07 2024
accepted: 05 08 2024
medline: 15 9 2024
pubmed: 15 9 2024
entrez: 14 9 2024
Statut: ppublish

Résumé

Three-dimensional (3D) printing has been used in medicine with applications in many different fields. 3D printing allows patient education, interventionalists training, preprocedural planning, and assists the interventionalist to improve treatment outcomes. 3D printing represents a potential advancement by allowing the printing of flexible vascular models. In this article, the authors report a clinical case using 3D printing to perform a physician-modified fenestrated endograft. An overview of 3D printing in vascular and endovascular surgery is provided, focusing on its potential applications for training, education, preprocedural planning, and current clinical applications.

Identifiants

pubmed: 39277349
pii: S0895-7967(24)00047-4
doi: 10.1053/j.semvascsurg.2024.08.002
pii:
doi:

Types de publication

Journal Article Case Reports Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

326-332

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this article.

Auteurs

Bahaa Nasr (B)

Univ Brest, Institut National de la Santé et de la Recherche Médicale, IMT-Atlantique, UMR1011 LaTIM, Vascular and Endovascular Surgery Department, Centre Hospitalier Universitaire Cavale Blanche, Boulevard Tanguy Prigent, 29200 Brest, France. Electronic address: nasr.bahaa@gmail.com.

Fabien Lareyre (F)

Department of Vascular Surgery, Hospital of Antibes Juan-les-Pins, France; Université Côte d'Azur, Le Centre National De La Recherche Scientifique, UMR7370, LP2M, Nice, France; Fédération Hospitalo-Universitaire Plan&Go, Nice, France.

Samuel Guigo (S)

W.Print, Clinical Research and Innovation Department, Centre Hospitalier Universitaire Cavale Blanche, Brest, France.

Kevin Bellenger (K)

W.Print, Clinical Research and Innovation Department, Centre Hospitalier Universitaire Cavale Blanche, Brest, France.

Juliette Raffort (J)

Université Côte d'Azur, Le Centre National De La Recherche Scientifique, UMR7370, LP2M, Nice, France; Fédération Hospitalo-Universitaire Plan&Go, Nice, France; Clinical Chemistry Laboratory, University Hospital of Nice, France; Institute 3IA Côte d'Azur, Université Côte d'Azur, France.

Yann Gouëffic (Y)

Groupe Hospitalier Paris St Joseph, Service de Chirurgie Vasculaire et Endovasculaire, F-75014.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH